Empowering clinicians with AI medical technologies that solve real challenges.

About Us

Keya Medical is redefining how clinicians evaluate and manage coronary artery disease through advanced artificial intelligence and data-driven imaging analysis.

Keya Medical is an international medical technology company specializing in deep learning-based solutions for cardiovascular diagnosis. Its flagship product, DEEPVESSEL FFR, is an FDA-cleared, CE-marked, NMPA-approved, and certified by HSA of Singapore CT-FFR analysis that provides non-invasive coronary artery assessment using CCTA.

Headquartered in Seattle, Washington, and Shenzhen, China, Keya Medical operates across Asia, Europe, and North America. Our solutions are supported by regulatory approvals, including FDA 510(k) clearance, CE Mark, and NMPA certification, with deployments in leading hospitals and imaging centers worldwide. Keya Medical has been featured at international cardiovascular and imaging conferences, including SCCT, ECR, and RSNA.

To learn more about Keya Medical, follow us on LinkedInTwitter, and Facebook.

Our Team

Letter from Mary-Pierre Waiss, President, North America

Welcome to Keya Medical.

Here, we believe that behind every scan, every diagnosis, and every innovation is a person — someone’s parent, child, or friend. That’s why our team is dedicated to combining cutting-edge deep learning technology with a deep sense of care.

Our presence in the United States continues to grow, and we are building a talented team committed to supporting clinicians, advancing research, and strengthening our partnerships across the cardiovascular community. Our advanced CCTA analysis tools are designed to help clinicians work faster and with greater accuracy.

Together, we’re shaping a future where heart health is stronger and patients’ outcomes are better.

Mary-Pierre Waiss – President, Keya Medical

Mary-Pierre Waiss

Mary-Pierre Waiss

President, North America

Mary Waiss is a seasoned leader in biotechnology and healthcare technology with deep experience advancing innovation in patient care. She has held leadership and board positions at leading organizations including Keya Medical, Evergreen Bioscience Innovation Cluster, Precision Image Analysis, VentriPoint Diagnostics, and Boston Children’s Hospital, part of the Harvard Medical School system. She is dedicated to driving progress in cardiovascular imaging and improving care for patients with cardiovascular disease.

Matt Dichard

Matt Dichard

Sales Director, Northeast Region

Matt Dichard is a healthcare executive with over 25 years of leadership in diagnostic imaging, healthcare technology, and SaaS. He has a strong record of driving revenue growth, expanding market share, and improving performance across sales, operations, and strategy. Matt has held senior roles with GE Healthcare, RAYUS Radiology, and regional imaging organizations. He joined Keya Medical to help accelerate the adoption of AI-enabled cardiovascular imaging that meaningfully improves patient care.
Chad Thomas

Chad Thomas

Sales Director, Central Region

Chad is an accomplished Commercial and Business Development Leader with 30 years of experience driving innovation in Cardiovascular Imaging, Medical Devices, and Health Technology. He has led commercial growth for Siemens Healthineers, Pie Medical Imaging, Caption Health, Bard Peripheral Vascular, and now Keya Medical, where he leads U.S. sales efforts in the Southeast region for AI-driven CT-FFR and, once FDA-approved, plaque analysis. Chad joined Keya Medical to help bring clinically-validated deep learning solutions to confidently, accurately, and reliably diagnose patients with Coronary Artery Disease — the number one cause of death globally.
Mitch McCahey

Mitch McCahey

Sales Director, West Region

Mitch McCahey is a veteran commercial sales and leadership executive with more than 30 years in cardiovascular medical devices at Boston Scientific, JNJ, Terumo, Medtronic, and Abbott. From 2019–2023, he helped lead HeartFlow’s CT-FFR adoption in the Pacific NW, establishing programs at Kaiser, Providence, Sutter, and the UC system, with his territory among the first to reach profitability. Mitch brings deep expertise in invasive and non-invasive FFR and strong knowledge of the U.S. cardiology and radiology markets.

Medical Advisors

John Rumberger, PhD, MD, FACC, MSCCT

John Rumberger, PhD, MD, FACC, MSCCT

Medical Director, Corazon Imaging

Dr. Rumberger is an accomplished medical professional and currently serves as the Medical Director at Corazon Imaging. His distinguished career includes serving as the Director of Cardiovascular Imaging at Princeton Longevity Center in New Jersey and as a former Professor of Medicine at the renowned Mayo Clinic. With his extensive fellowship in cardiology and an impressive portfolio of nearly 500 publications, he has made significant contributions to the field.

Irfan Shafique, MD

Irfan Shafique, MD

President, Forward Healthcare Consultans

Dr. Irfan Shafique is a renowned radiologist with extensive expertise in cardiac imaging. He is currently with Chesapeake Medical Imaging, overseeing the Cardiac Imaging program. Dr. Shafique is one of the pioneers of cardiac CTA imaging and training programs and courses at Johns Hopkins Bayview Medical Center. He is a former Johns Hopkins faculty member and co-directed the cardiac CT training practicum, and he continues to teach the CME course. 

Reseller Partners